Wearable optical fiber sensor based on a bend singlemode-multimode-singlemode fiber structure for respiration monitoring

Respiration rate (RR) is an important information related to human physiological health. A wearable optical fiber sensor for respiration monitoring based on a bend singlemode-multimodesinglemode (SMS) fiber structure, which is highly sensitive to bend, is firstly proposed and experimentally demonstrated. The sensor fastened by an elastic belt on the abdomen of a person will acquire the respiration signal when the person breaths, which will introduce front and back movement of the abdomen, and thus bend of SMS fiber structure. Short-time Fourier transform (STFT) method is employed for signal processing to extract characteristic information of both the time and frequency domain of the measured waveform, which provides accurate RR measurement. Six different SMS fiber sensors have been tested by six individuals and the experimental results demonstrated that the RR signals can be effectively monitored among different individuals, where an average Pearson Correlation Coefficient of 0.88 of the respiration signal has been achieved, which agrees very well with that of commercial belt respiration sensor. The proposed technique can provide a new wearable and portable solution for monitoring of respiratory with advantage of easy fabrication and robust to environment

Singlemode-Multimode-Singlemode Optical Fiber Sensor for Accurate Blood Pressure Monitoring

A dual-channel single-mode-multi-mode-single-mode (SMS) fiber optic sensor encapsulated by polydimethylsiloxane (PDMS) was proposed for the first time, for the simultaneous monitoring of the brachial and radial arteries for accurate blood pressure prediction. With the help of the machine learning algorithm Support Vector Regression (SVR), the SMS fiber sensor can continuously and accurately monitor the systolic and diastolic blood pressure. Commercial sphygmomanometers are used to calibrate the accuracy of blood pressure measurement. Compared with the single-channel system, this system can extract more pulse wave features for blood pressure prediction, such as radial artery transit time (RPTT), brachial artery transit time (BPTT), and the transit time difference between the radial artery and the brachial artery (DBRPTT). The results show that the performance of dual-channel blood pressure monitoring is more accurate than that of single-channel blood pressure monitoring in terms of the absolute value of the correlation coefficient (R) and the average value of the difference between SBP and DBP. In addition, both the single-channel and dual-channel blood pressure monitoring are in line with the Association for the Advancement of Medical Devices (AAMI), but the average deviation (DM, 0.06 mmHg) and standard deviation (SD, 1.54 mmHg) of dual-channel blood pressure monitoring are more accurate. The blood pressure monitoring system has the characteristics of low cost, high sensitivity, non-invasive and capability for remote real time monitoring, which can provide effective solution for intelligent health monitoring in the era of artificial intelligence in the future

Low-cost wearable sensor based on a D-shaped plastic optical fiber for respiration monitoring

A low cost, wearable textile-based respiratory sensing system is proposed and experimentally demonstrated. A highly sensitive D-shaped plastic optical fiber (POF) sensor that responds to bending is integrated into an elastic band structure to form a respiratory sensing system. The curvature sensing experiments were conducted on the D-shaped POF sensor, which has a coefficient of determination (R2) of 0.9977. The system can be used to monitor not only the respiratory rate (RR) of the human body under different movement states (resting, walking and running), but also the RR of steady and unsteady respiratory signals due to different physiological states. In addition, using the proposed signal processing technique, the interference of motion noise can be removed and the influence of body movement on the sensor response can be eliminated. The advantages of the system are its low cost, compactness and simplicity in design. Thus, the application of the proposed respiratory sensing system provides a simple and inexpensive optical solution for wearable health

類比對電腦概念學習的影響

資訊教育學系

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2

Entry inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed to control the outbreak of coronavirus disease 2019 (COVID-19). This study developed a robust and straightforward assay that detected the molecular interaction between the receptor-binding domain (RBD) of viral spike protein and the angiotensin-converting enzyme 2 (ACE2) receptor in just 10 min. A drug library of 1068 approved compounds was used to screen for SARS-CoV2 entry inhibition, and 9 active drugs were identified as specific pseudovirus entry inhibitors. A plaque reduction neutralization test using authentic SARS-CoV-2 virus in Vero E6 cells confirmed that 2 of these drugs (Etravirine and Dolutegravir) significantly inhibited the infection of SARS-CoV-2. With molecular docking, we showed that both Etravirine and Dolutegravir are preferentially bound to primary ACE2-interacting residues on the RBD domain, implying that these two drug blocks may prohibit the viral attachment of SARS-CoV-2. We compared the neutralizing activities of these entry inhibitors against different pseudoviruses carrying spike proteins from alpha, beta, gamma, and delta variants. Both Etravirine and Dolutegravir showed similar neutralizing activities against different variants, with EC50 values between 4.5 to 5.8 nM for Etravirine and 10.2 to 22.9 nM for Dolutegravir. These data implied that Etravirine and Dolutegravir may serve as general spike inhibitors against dominant viral variants of SARS-CoV-2

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2

Entry inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed to control the outbreak of coronavirus disease 2019 (COVID-19). This study developed a robust and straightforward assay that detected the molecular interaction between the receptor-binding domain (RBD) of viral spike protein and the angiotensin-converting enzyme 2 (ACE2) receptor in just 10 min. A drug library of 1068 approved compounds was used to screen for SARS-CoV2 entry inhibition, and 9 active drugs were identified as specific pseudovirus entry inhibitors. A plaque reduction neutralization test using authentic SARS-CoV-2 virus in Vero E6 cells confirmed that 2 of these drugs (Etravirine and Dolutegravir) significantly inhibited the infection of SARS-CoV-2. With molecular docking, we showed that both Etravirine and Dolutegravir are preferentially bound to primary ACE2-interacting residues on the RBD domain, implying that these two drug blocks may prohibit the viral attachment of SARS-CoV-2. We compared the neutralizing activities of these entry inhibitors against different pseudoviruses carrying spike proteins from alpha, beta, gamma, and delta variants. Both Etravirine and Dolutegravir showed similar neutralizing activities against different variants, with EC50 values between 4.5 to 5.8 nM for Etravirine and 10.2 to 22.9 nM for Dolutegravir. These data implied that Etravirine and Dolutegravir may serve as general spike inhibitors against dominant viral variants of SARS-CoV-2

Preoperative Induction Therapy for Locally Advanced Thymic Tumors: A Retrospective Analysis Using the ChART Database

Background and objective To evaluate the role of preoperative induction therapy on prognosis of locally advanced thymic malignancies. Methods Between 1994 and 2012, patients received preoperative induction therapies (IT group) in the Chinese Alliance for Research in Thymomas (ChART) database, were compared with those having surgery directly after preoperative evaluation (DS group). All tumors receiving induction therapies were locally advanced (clinically stage III-IV) before treatment and those turned out to be in pathological stage I and II were considered downstaged by induction. Clinical pathological characteristics were retrospectively analyzed. To more accurately study the effect of induction therapies, stage IV patients were then excluded. Only stage I-III tumors in the IT group and stage III cases in the DS group were selected for further comparison in a subgroup analysis. Results Only 68 (4%) out of 1,713 patients had induction therapies, with a R0 resection of 67.6%, 5-year recurrence of 44.9%, and 5- and 10-year overall survivals (OS) of 49.7% and 19.9%. Seventeen patients (25%) were downstaged after induction. Significantly more thymomas were downstaged than thymic carcinomas (38.7% vs 13.9%, P=0.02). Tumors downstaged after induction had significantly higher 5-year OS than those not downstaged (93.8% vs 35.6%, P=0.013). For the subgroup analysis when stage IV patients were excluded, 5-year OS was 85.2% in the DS group and 68.1% in the IT group (P<0.001), although R0 resection were similar (76.4% vs 73.3%, P=0.63). However, 5-year OS in tumors downstaged after induction (93.8%) was similar to those in the DS group (85.2%, P=0.438), both significantly higher than those not downstaged after induction (35.6%, P<0.001). Conclusion Only 68 (4%) out of 1,713 patients had induction therapies, with a R0 resection of 67.6%, 5-year recurrence of 44.9%, and 5- and 10-year overall survivals (OS) of 49.7% and 19.9%. Seventeen patients (25%) were downstaged after induction. Significantly more thymomas were downstaged than thymic carcinomas (38.7% vs 13.9%, P=0.02). Tumors downstaged after induction had significantly higher 5-year OS than those not downstaged (93.8% vs 35.6%, P=0.013). For the subgroup analysis when stage IV patients were excluded, 5-year OS was 85.2% in the DS group and 68.1% in the IT group (P<0.001), although R0 resection were similar (76.4% vs 73.3%, P=0.63). However, 5-year OS in tumors downstaged after induction (93.8%) was similar to those in the DS group (85.2%, P=0.438), both significantly higher than those not downstaged after induction (35.6%, P<0.001)

Thymectomy versus Tumor Resection for Early-stage Thymic Malignancies: A Chinese Alliance for Research in Thymomas (ChART) Retrospective Database Analysis

Background and objective To evaluate the surgical outcomes of tumor resection with or without total thymectomy for thymic epithelial tumors (TETs) using the Chinese Alliance for Research in Thymomas (ChART) retrospective database. Methods Patients without preoperative therapy, who underwent surgery for early-stage (Masaoka-Koga stage I and II) tumors, were enrolled for the study. They were divided into thymectomy and thymomectomy groups according to the resection extent of the thymus. Demographic and surgical outcomes were compared between the two patients groups. Results A total of 1,047 patients were enrolled, with 796 cases in the thymectomy group and 251 cases in the thymomectomy group. Improvement rate of myasthenia gravis (MG) was higher after thymectomy than after thymomectomy (91.6% vs 50.0%, P<0.001). Ten-year overall survival was similar between the two groups (90.9% after thymectomy and 89.4% after thymomectomy, P=0.732). Overall, recurrence rate was 3.1% after thymectomy and 5.4% after thymomectomy, with no significant difference between the two groups (P=0.149). Stratified analysis revealed no significant difference in recurrence rates in Masaoka-Koga stage I tumors (3.2% vs 1.4%, P=0.259). However in patients with Masaoka-Koga stage II tumors, recurrence was significantly less after thymectomy group than after thymomectomy (2.9% vs 14.5%, P=0.001). Conclusion Thymectomy, instead of tumor resection alone, should still be recommended as the surgical standard for thymic malignancies, especially for stage II tumors and those with concomitant MG